Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Macimorelin is a growth hormone secretagogue and agonist of growth hormone secretagogue receptor 1a (GHS-R1a).1 It binds to GHS-R1a (IC50 = 123 nM for the human receptor). Oral administration of macimorelin (1 mg/kg) increases plasma growth hormone levels in dogs. It decreases gastric acid secretion in pylorus-ligated rats when administered intracerebroventricularly at doses of 0.01 or 1 nmol/animal.2 Macimorelin (10 mg/kg) increases acute food intake and body weight in mice.3 It decreases the number and total duration of seizures in mice induced with dopamine D1 receptor kindling using SKF 81297.4 Formulations containing macimorelin have been used in the diagnosis of adult growth hormone deficiency.
WARNING This product is not for human or veterinary use.
1. New active series of growth hormone secretagogues. J. Med. Chem. 46(7), 1191-1203 (2003).
2. Evidence for a role of the GHS-
3. Ghrelin agonist JMV 1843 increases food intake, body weight and expression of orexigenic neuropeptides in mice. Physiol. Res. 62(4), 435-444 (2013).
4. Differential effects of a full and biased ghrelin receptor agonist in a mouse kindling model. Int. J. Mol. Sci. 20(10), 2480 (2019).